Eloxx Pharmaceuticals Statistics
Total Valuation
ELOX has a market cap or net worth of 659,352. The enterprise value is 8.69 million.
| Market Cap | 659,352 |
| Enterprise Value | 8.69M |
Important Dates
The next estimated earnings date is Thursday, May 14, 2026.
| Earnings Date | May 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ELOX has 5.07 million shares outstanding. The number of shares has increased by 466.95% in one year.
| Current Share Class | 5.07M |
| Shares Outstanding | 5.07M |
| Shares Change (YoY) | +466.95% |
| Shares Change (QoQ) | +24.20% |
| Owned by Insiders (%) | 33.76% |
| Owned by Institutions (%) | 2.46% |
| Float | 2.11M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | -0.09 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.08 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.53
| Current Ratio | 0.53 |
| Quick Ratio | 0.40 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -8.59 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 118.82% |
| Weighted Average Cost of Capital (WACC) | -43,890.06% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -804,000 |
| Employee Count | 10 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +129,900.00% in the last 52 weeks. The beta is -151,095.14, so ELOX's price volatility has been lower than the market average.
| Beta (5Y) | -151,095.14 |
| 52-Week Price Change | +129,900.00% |
| 50-Day Moving Average | 0.07 |
| 200-Day Moving Average | 0.21 |
| Relative Strength Index (RSI) | 51.70 |
| Average Volume (20 Days) | 6,998 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -9.01M |
| Pretax Income | -8.04M |
| Net Income | -8.04M |
| EBITDA | n/a |
| EBIT | -9.01M |
| Earnings Per Share (EPS) | -0.35 |
Balance Sheet
The company has 6.36 million in cash and 11.82 million in debt, with a net cash position of -5.46 million or -1.08 per share.
| Cash & Cash Equivalents | 6.36M |
| Total Debt | 11.82M |
| Net Cash | -5.46M |
| Net Cash Per Share | -1.08 |
| Equity (Book Value) | -7.58M |
| Book Value Per Share | -1.49 |
| Working Capital | -7.58M |
Cash Flow
| Operating Cash Flow | -12.98M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 35,000 |
| Net Borrowing | 1.31M |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ELOX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -466.95% |
| Shareholder Yield | -466.95% |
| Earnings Yield | -1,219.38% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on December 2, 2022. It was a reverse split with a ratio of 0.025.
| Last Split Date | Dec 2, 2022 |
| Split Type | Reverse |
| Split Ratio | 0.025 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |